Cas3 Biotherapeutics
Biotechnology Research
Cambridge, Ma, United States
3 employees
- Employees
- 3
- Contacts
- 1
- Emails
- 1
Cas3 Biotherapeutics Overview
- Headquarters
- Cambridge, Ma, United States
- Industry
- Biotechnology Research
- Employees
- 3
- Founded
- 2024
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Cas3 Biotherapeutics
Cas3 Biotherapeutics, Inc. is a biotechnology company discovering and developing oncology therapies using CRISPR-Cas3 to genotypically target tumor-specific mutations and destroy cancer cells. Our proprietary Type I(E) CRISPR-Cas3 system precisely targets mutations as small as a single base and disrupts large segments of DNA to disrupt essential genes.
Cas3 Biotherapeutics Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
Cas3 Biotherapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Shane Ward | Public Company Executive - Biopharma | Greater Boston, United States |
Email
|
Compare Similar Companies to Cas3 Biotherapeutics
BTIG
Financial Services
Editas Medicine
Biotechnology Research
scPharmaceuticals
Pharmaceutical Manufacturing
Vizgen
Biotechnology Research
Cidara Therapeutics
Biotechnology
Ultivue by Vizgen
Biotechnology Research
AI Proteins
Biotechnology Research
UCR
Robotics Engineering
BioLink Therapeutics
Biotechnology Research
Loopin
Consumer Services